New findings on drug tolerance in TB suggest ideas for shorter cures
Thursday, March 3, 2011 - 14:31
in Health & Medicine
A study of host-pathogen responses in tuberculosis elucidates molecular mechanisms of antibiotic tolerance in tuberculosis and further suggests a strategy for shortening curative therapy (currently six months) using a class of drugs -- efflux pump inhibitors -- that are already approved for treating high blood pressure and angina, and available for use in people.